Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CoreWeave, Inc. (Nasdaq: CRWV) SEC filings page provides access to the company’s regulatory disclosures, including current reports on Form 8-K and other key documents filed with the U.S. Securities and Exchange Commission. As a publicly traded Software - Infrastructure company focused on AI cloud services, CoreWeave uses its filings to describe material agreements, financing arrangements, and significant corporate events.
In its Form 8-K filings, CoreWeave has reported material definitive agreements such as master services agreements and order forms with OpenAI, Meta Platforms, Inc., and NVIDIA Corporation, which govern access to cloud computing capacity and reserved capacity arrangements. The company has also disclosed credit agreements and delayed draw term loan facilities used to finance capital expenditures for GPU servers, infrastructure, and systems that support strategic customer contracts.
CoreWeave’s filings include detailed descriptions of its debt and capital structure, such as senior notes, revolving credit facilities, and convertible senior notes due 2031. These documents outline terms like interest rates, maturity dates, conversion features, capped call transactions, guarantees by subsidiaries, and financial covenants. Investors can review these filings to understand how CoreWeave funds its AI infrastructure and manages potential dilution.
Other 8-K filings cover topics such as the termination of a proposed merger agreement, changes in classification of equity related to preferred stock put rights, and the registration of Class A common stock on The Nasdaq Stock Market LLC under the symbol CRWV. Results of operations and financial condition for specific quarters are also furnished via 8-K exhibits.
On Stock Titan, AI-powered tools can help summarize lengthy CoreWeave filings, highlight key terms in documents like credit agreements and indentures, and surface information on topics such as material customer contracts, new financing facilities, and significant corporate events. Users can quickly locate references to items like convertible notes, capped call transactions, or major AI infrastructure commitments without reading every page.
CRWV insiders filed a Form 144 reporting proposed sales of common stock. The filing lists multiple 10b5-1 and related sales entries, including West Clay Capital and individual filings for Brian Venturo. Examples include proposed sales of 281,250 shares and 52,473 shares on specified dates.
An insider of CRWV filed a Rule 144 notice to sell up to 8,315 common shares through Morgan Stanley Smith Barney LLC on NASDAQ around 02/17/2026, with an indicated aggregate market value of $798,572.60. These shares are listed as founder shares acquired on 02/25/2019 from the issuer.
The filing also details prior three‑month sales of CRWV common stock under Rule 10b5‑1 trading plans by Brannin McBee, several related trusts and GRATs, and a non‑affiliate donee. Individual line items show repeated scheduled sales ranging from a few hundred to over one hundred thousand shares per transaction with multi‑million‑dollar gross proceeds.
CRWV received a Rule 144 notice from a shareholder planning to sell 102,830 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $9,875,793.20. The filing states that 386,401,201 shares of common stock were outstanding and lists NASDAQ as the exchange, with an approximate sale date of 02/17/2026.
The shares to be sold are described as Founder Shares acquired from the issuer on 02/25/2019. The notice also details numerous recent Rule 10b5-1 sales of CRWV common stock over the past three months by trusts and entities associated with the same address, each reporting specific share amounts and gross proceeds.
An affiliate of CRWV has filed a Form 144 notice to sell 1,000 shares of common stock. The planned sale, with an aggregate market value of $96,040, is to be executed through Morgan Stanley Smith Barney LLC, with the shares listed on the NASDAQ.
The filing also details how the 1,000 shares were originally acquired as founder shares on February 25, 2019. In addition, it lists extensive recent Rule 10b5-1 sales by related trusts and entities over the past three months, showing multiple programmed dispositions of CRWV common stock.
A shareholder has filed a notice to sell 1,000 shares of common stock, with an aggregate market value of $96,040.00. The shares are planned to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/17/2026 on NASDAQ. The securities were originally acquired as founders shares from the issuer on 02/25/2019, with 1,000 shares acquired on that date.
The filing also lists extensive prior sales of the issuer’s common stock over the past three months under Rule 10b5-1 trading plans for various trusts and entities associated with the same address in Livingston, New Jersey. Examples include a sale by a Non-Affiliate Donee of 257,733 shares for gross proceeds of $19,592,527.61 on 12/01/2025 and a sale by BRANNIN MCBEE of 57,636 shares for $4,182,723.27 on 12/31/2025. The signer represents that they do not know any material adverse, nonpublic information about the issuer’s operations.
CRWV has a notice of proposed sale under Rule 144 covering 25,000 shares of common stock, with an aggregate market value of $2,401,000. The filing lists Morgan Stanley Smith Barney LLC as broker, with an approximate sale date of 02/17/2026 on NASDAQ. Shares outstanding were 386,401,201 when reported.
The seller acquired these 25,000 shares on 02/25/2019 as founder shares from the issuer. The document also details extensive prior three‑month Rule 10b5‑1 sales in CRWV common stock by Brannin J. McBee, related trusts and entities, and a Non‑Affiliate Donee, including individual transactions such as 257,733 shares sold for $19,592,527.61.
CRWV has a Form 144 notice covering a proposed sale of 500 shares of its common stock through Morgan Stanley Smith Barney, with an aggregate market value of $48,020. The shares are described as founders’ common stock acquired from the issuer on 02/25/2019 and fully paid that day.
The filing also lists extensive recent Rule 10b5-1 sales of CRWV common stock during the prior three months by multiple named sellers, including BRANNIN MCBEE, the Brannin J. McBee 2022 Irrevocable Trust, several Canis Major and Canis Minor family and GRAT trusts, and a Non-Affiliate Donee. Individual entries show large blocks such as 102,835 shares sold for over $10 million and 257,733 shares sold for about $19.6 million, illustrating significant ongoing disposition activity under pre-arranged trading plans.
A shareholder of CRWV has filed a Form 144 notice to sell 3,000 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/17/2026, to be sold on NASDAQ at an aggregate market value of $288,120.00.
The notice shows these shares are founder shares acquired from the issuer on 02/25/2019. It also lists numerous prior Rule 10b5-1 common stock sales over the past three months by related trusts and accounts, along with the amounts and gross proceeds for each completed transaction.
CRWV received a Form 144 notice from a shareholder planning to sell 25,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $2,401,000. The filing lists 386,401,201 common shares outstanding and identifies NASDAQ as the trading market.
The 25,000 shares to be sold are described as founder shares acquired on 02/25/2019. The document also details extensive prior three‑month sales under Rule 10b5‑1 trading plans by various trusts and entities associated with the same address, including individual sales such as 102,835 common shares sold for $9,799,589.34 on 01/20/2026 and 257,733 shares sold for $19,592,527.61 on 12/01/2025.
CoreWeave, Inc. CEO and President Michael N. Intrator reported a series of open‑market sales of Class A Common Stock on February 11, 2026, under a Rule 10b5‑1 trading plan adopted on May 23, 2025. The direct sales, all coded “S,” occurred in multiple small blocks at weighted‑average prices ranging from about $89 to $97 per share, leaving him with 5,763,868 Class A shares held directly.
On the same date, Omnadora Capital LLC, an entity for which Intrator is the manager of its manager, converted 50,000 shares of Class B Common Stock into 50,000 Class A shares and then executed multiple open‑market sales of those Class A shares, reducing Omnadora’s Class A position to zero. Intrator is also reported as having large remaining Class B holdings directly and through several family trusts, each share of Class B being convertible into one Class A share.
CoreWeave, Inc. CEO and President Michael N. Intrator reported a series of open‑market sales of Class A Common Stock on February 11, 2026, under a Rule 10b5‑1 trading plan adopted on May 23, 2025. The direct sales, all coded “S,” occurred in multiple small blocks at weighted‑average prices ranging from about $89 to $97 per share, leaving him with 5,763,868 Class A shares held directly.
On the same date, Omnadora Capital LLC, an entity for which Intrator is the manager of its manager, converted 50,000 shares of Class B Common Stock into 50,000 Class A shares and then executed multiple open‑market sales of those Class A shares, reducing Omnadora’s Class A position to zero. Intrator is also reported as having large remaining Class B holdings directly and through several family trusts, each share of Class B being convertible into one Class A share.